Case reference: CE/9531-11
Start date: August 2011
In August 2011, the OFT opened an investigation into certain patent dispute settlement agreements relating to Paroxetine, a medicine used in the treatment of disorders such as depression and anxiety disorder.
The OFT continues to consider this matter as an administrative priority and is pursuing the investigation under Chapter I of the Competition Act 1998 and Article 101 of the Treaty on the Functioning of the European Union.
At this stage of the investigation, the OFT has not yet concluded whether it considers the law has been infringed. The OFT intends to issue an update on the progress of the investigation during the Summer of 2012.
Senior responsible officer: Ann Pope (020 7211 8786, ann.pope@oft.gsi.gov.uk)
Project director: Geoffrey Steadman (020 7211 8810, geoffrey.steadman@oft.gsi.gov.uk)
Team Leader: Dan Moore (020 7211 5828, dan.moore@oft.gsi.gov.uk)
Any media enquiries should be directed to a member of our Press Office.
This feature requires Javascript and Cookies to be enabled on your browser
Register for email alerts or amend your existing account details here.